Terminal · Institutions
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
KPCB XIII Associates, LLC (CIK 1500595) reported $185.7M across 3 reported positions in its SEC 13F filing for 2023-09-30. Largest positions: PGNY ($172.6M, 92.97%), LUNG ($10.3M, 5.53%), MVLA ($2.8M, 1.50%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | PGNY | Progyny, Inc. | $172.6M | 92.97% | 5.1M | Hold |
| 2 | LUNG | Pulmonx Corporation | $10.3M | 5.53% | 994,971 | Hold |
| 3 | MVLA | Movella Holdings Inc. | $2.8M | 1.50% | 5.2M | Hold |
Source: SEC Form 13F filings · as of 2023-09-30